Is Curing Patients A Bad Business Model

One question says everything: “Is curing patients a sustainable business model?” This clip goes straight at the incentive structure behind modern pharma, where long-term dependency is often more profitable than real recovery. Add in the billions paid in civil and criminal fines over the years, and the bigger point gets hard to ignore, this is not a system built to lose customers.

Check Also

Why Some People Had Severe COVID While Others Didn’t

Why did some people experience severe COVID while others with similar risk factors did not? This clip explores the idea that disease severity may involve more than just the presence of underlying conditions. It discusses the role of immune regulation, chronic inflammation, cytokine storms, and how nutrients involved in immune function may influence the body's ability to respond and recover.